Skip to main content

HDV

0
Pipeline Programs
3
Companies
2
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Gilead Sciences
Gilead SciencesFOSTER CITY, CA
2 programs
Thailand HDV CohortN/A
Thailand HDV CohortN/A
Kite Pharma
Kite PharmaCA - El Segundo
1 program
Thailand HDV CohortN/A1 trial
Active Trials
NCT05350865Recruiting3,152Est. May 2025
ETS
ETSMO - Rolla
1 program
ePro Diary - HDV ( MACROLIVER )N/A1 trial
Active Trials
NCT07442760Recruiting55Est. Mar 2030

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
2027
2028
2029
2030
ETSePro Diary - HDV ( MACROLIVER )
Kite PharmaThailand HDV Cohort

Clinical Trials (2)

Total enrollment: 3,207 patients across 2 trials

NCT07442760ETSePro Diary - HDV ( MACROLIVER )

ePro Diary - HDV ( MACROLIVER )

Start: Mar 2025Est. completion: Mar 203055 patients
N/ARecruiting
NCT05350865Kite PharmaThailand HDV Cohort

Thailand HDV Cohort

Start: Jan 2023Est. completion: May 20253,152 patients
N/ARecruiting

Related Jobs

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 actively recruiting trials targeting 3,207 patients
3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.